CART Peptide
Cocaine- and Amphetamine-Regulated Transcript Peptide (CART(55-102))
48 Amino Acids · MW: Approximately 5,700 Da
Amino Acids
48
Molecular Weight
Approximately 5,700 Da
Half-life
Minutes to hours; not well established
Research Score
3.9
Studies
64
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is CART Peptide?
CART is a satiety-linked neuropeptide system that suppresses feeding and modulates energy expenditure. CART-derived fragments are used in research because of their anorexigenic effects and central role in appetite regulation.
Key Benefits & Mechanisms
food-intake suppression
satiety signaling
hypothalamic appetite modulation
energy-expenditure effects
Research Summary
CART peptides have strong evidence in animal models for reducing food intake and body-weight gain through hypothalamic pathways. Human translational work is more limited, but CART signaling remains a well-established appetite-regulation target.
Related Peptides
Oxyntomodulin
Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.
Weight ManagementCotadutide
MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Cotadutide is a synthetic oxyntomodulin analogue designed to engage both GLP-1 and glucagon receptors. It was developed to improve weight loss and metabolic markers in obesity and type 2 diabetes research.
Weight ManagementMazdutide
IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist
Mazdutide is a long-acting oxyntomodulin-inspired dual agonist being developed for obesity and metabolic disease. It is designed to drive clinically meaningful weight loss while improving glucose and lipid parameters.
Weight ManagementDulaglutide
Recombinant GLP-1 receptor agonist Fc fusion protein
Dulaglutide is a long-acting GLP-1 receptor agonist used primarily in type 2 diabetes. It consistently produces modest weight loss and is widely studied as a benchmark incretin mimetic.
Weight Management